Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response.
about
Insulin therapy for type 2 diabetes.Pharmacotherapy for the treatment of patients with type 2 diabetes mellitus: rationale and specific agents.The new diabetes inhalers: new tools for the clinician.Understanding insulins: new developments.The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
P2860
Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Novel insulins and strict glyc ...... al insulin secretory response.
@ast
Novel insulins and strict glyc ...... al insulin secretory response.
@en
type
label
Novel insulins and strict glyc ...... al insulin secretory response.
@ast
Novel insulins and strict glyc ...... al insulin secretory response.
@en
prefLabel
Novel insulins and strict glyc ...... al insulin secretory response.
@ast
Novel insulins and strict glyc ...... al insulin secretory response.
@en
P2093
P2860
P356
P1476
Novel insulins and strict glyc ...... al insulin secretory response.
@en
P2093
Irl B Hirsch
John R White
R Keith Campbell
P2860
P356
10.3810/PGM.2003.06.1426
P407
P577
2003-06-01T00:00:00Z